Evidence map›Paper›PMID 21565561›Full record

ArticleClinical immunology (Orlando, Fla.)2011

Thymic microenvironment reconstitution after postnatal human thymus transplantation.

Bin Li, Jie Li, Blythe H Devlin, M Louise Markert

5 registry-linked trialsAbstract read
In one paragraph

Article in Clinical immunology (Orlando, Fla.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 5 registered trials, which are not on this map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00576407 phase2completednot on this map

Phase II Study of Thymus Transplantation in Complete DiGeorge Syndrome #668

TypeinterventionalSponsorSumitomo Pharma Switzerland GmbHRan1991 to 2017Enrolled26ConditionsDiGeorge Syndrome, Complete Typical DiGeorge AnomalyArmsCultured Thymus Tissue for Implantation (CTTI)
NCT00576836 phase2completednot on this map

Dose Study of Thymus Transplantation in DiGeorge Anomaly, IND 9836, #932.1

TypeinterventionalSponsorSumitomo Pharma Switzerland GmbHRan2004 to 2019Enrolled7ConditionsDiGeorge Anomaly, DiGeorge Syndrome, Complete DiGeorge Anomaly, Complete DiGeorge SyndromeArmsCultured Thymus Tissue Implantation (CTTI), Cultured Thymus Tissue Implantation with Parathyroid Transplantation
NCT00579527 phase1 / phase2completednot on this map

Phase I/II Trial of Thymus Transplantation With Immunosuppression, #950

TypeinterventionalSponsorSumitomo Pharma Switzerland GmbHRan2005 to 2017Enrolled14ConditionsDiGeorge Anomaly, Complete DiGeorge Anomaly, Complete Atypical DiGeorge Anomaly, Complete DiGeorge SyndromeArmsCultured Thymus Tissue for Implantation (CTTI), Cultured Thymus Tissue Implantation and Parental Parathyroid Transplantation, Blood Draw, Rabbit anti-thymocyte globulin, Cyclosporine
NCT01220531 nacompletednot on this map

Safety and Efficacy of Thymus Transplantation in Complete DiGeorge Anomaly, IND#9836

TypeinterventionalSponsorSumitomo Pharma Switzerland GmbHRan2010 to 2023Enrolled29ConditionsComplete DiGeorge Anomaly, DiGeorge Syndrome, DiGeorge Anomaly, Complete DiGeorge SyndromeArmsCultured Thymus Tissue
NCT02274662 phase4completednot on this mapstarted 2014, after this paper: background citation

Expanded Access Protocol Thymus Transplantation for Immunodeficiency, Hematologic Malignancies, and Autoimmune Disease Related to Poor Thymic Function

TypeinterventionalSponsorSumitomo Pharma Switzerland GmbHRan2014 to 2023Enrolled11ConditionsPoor Thymic Function, Immunodeficiency, Athymia, ImmunoreconstitutionArmsCultured Thymus Tissue, Blood Draw, Rabbit Anti-Thymocyte Globulin and Cyclosporine or Tacrolimus
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Reconstitution of thymopoiesis via implantation of cryopreserved cultured thymus tissue into athymic recipients.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. T cell Tolerance in Early Life.Frontiers in immunology · 2020
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Primary Immune Deficiency Treatment Consortium (PIDTC) update.The Journal of allergy and clinical immunology · 2016
    Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Bin LiDepartment of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA.
Jie Li
Blythe H Devlin
M Louise Markert
Duke Medical Center · USDuke University Hospital · US

Funding

THYMIC TRANSPLANTATION IN COMPLETE DIGEORGE SYNDROMER01AI047040 · NIAID · DUKE UNIVERSITY · PI MARKERT, M. LOUISE · 1999 to 2014
$8.0M
Thymic Transplantation in Complete DiGeorge SyndromeR56AI047040 · NIAID · DUKE UNIVERSITY · PI MARKERT, M. LOUISE · 2009 to 2009
$1.2M
NIAID NIH HHS R01 AI047040NIAID NIH HHS R56 AI047040PHS HHS R01 AK 47040
6 · The paper itself

Abstract

A functional thymus develops after cultured thymus tissue is transplanted into subjects with complete DiGeorge anomaly. To gain insight into how the process occurs, 7 post-transplantation thymus biopsy tissues were evaluated. In 5 of 7 biopsies, the thymus appeared to be predominantly cortex with thymocytes expressing cortical markers. Unexpectedly, the epithelium expressed both cortical [cortical dendritic reticulum antigen 2 (CDR2)] and medullary [cytokeratin (CK) 14] markers. Early medullary development was suggested by epithelial cell adhesion molecule (EpCAM) reactivity in small areas of biopsies. Two other biopsies had distinct mature cortex and medulla with normal restriction of CK14 to the medulla and subcapsular cortex, and of CDR2 to cortex. These data are consistent with a model in which thymic epithelium contains CK14+ "progenitor epithelial cells". After transplantation these cells proliferate as CK14+CDR2+ thymic epithelial cells that are associated with cortical thymocytes. Later these cells differentiate into distinct cortical and medullary epithelia.

Indexed as

BiopsyCell DifferentiationDiGeorge SyndromeHumansInfantInfant, NewbornKeratin-14Lymphocyte ActivationNerve Tissue ProteinsStem CellsThymus GlandT-LymphocytesCDR2 protein, humanKeratin-14Nerve Tissue Proteins

Identifiers

PMID21565561
PMCPMC3159734
OpenAlexW2081730011

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.